| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Centre National de la Recherche Scientifique-UPR 0415 and Université Paris VII, Institut Cochin de Génétique Moléculaire (L.B., L.P., A.D.S., R.J.), F-75014 Paris, France; Rowett Research Institute (L.B.), Bucksburn, Aberdeen, United Kingdom AB2 9SB; and Institut de Recherches Internationales Servier (P.D.), F-92415 Courbevoie, France
Address all correspondence and requests for reprints to: Dr. Ralf Jockers, Centre National de la Recherche Scientifique, UPR415, Institut Cochin de Génétique Moléculaire, 22 rue Méchain, F-75014 Paris, France. E-mail: jockers{at}cochin.inserm.fr
Several reports have demonstrated that the pineal hormone, melatonin, plays an important role in body mass regulation in mammals. To date, however, the target tissues and relevant biochemical mechanisms involved remain uncharacterized. As adipose tissue is the principal site of energy storage in the body, we investigated whether melatonin could also act on this tissue. Semiquantitative RT-PCR analysis revealed the expression of MT1 and MT2 melatonin receptor mRNAs in the human brown adipose cell line, PAZ6, as well as in human brown and white adipose tissue. Binding analysis with 2-[125I]iodomelatonin (125I-Mel) revealed the presence of a single, high affinity binding site in PAZ6 adipocytes with a binding capacity of 7.46 ± 1.58 fmol/mg protein and a Kd of 457 ± 5 pM. Both melatonin and the MT2 receptor-selective antagonist, 4-phenyl-2-propionamidotetraline, competed with 2-[125I]iodomelatonin binding, with respective Ki values of 3 x 10-11 and 1.5 x 10-11 M. Functional expression of melatonin receptors in PAZ6 adipocytes was indicated by the melatonin-induced, dose-dependent inhibition of forskolin-stimulated cAMP levels and basal cGMP levels with IC50 values of 2 x 10-9 and 3 x 10-10 M, respectively. Modulation of the cGMP pathway by melatonin further supports functional expression of MT2 receptors, as this pathway was shown to be specific for that subtype in humans. In addition, long-term melatonin treatment of PAZ6 adipocytes was found to decrease the expression of the glucose transporter Glut4 and glucose uptake, an important parameter of adipocyte metabolism. These results suggest that melatonin may act directly at MT2 receptors on human brown adipocytes to regulate adipocyte physiology.
This article has been cited by other articles:
![]() |
J. M. Gimble and Z. E. Floyd Fat circadian biology J Appl Physiol, November 1, 2009; 107(5): 1629 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Torres-Farfan, F. J. Valenzuela, M. Mondaca, G. J. Valenzuela, B. Krause, E. A. Herrera, R. Riquelme, A. J. Llanos, and M. Seron-Ferre Evidence of a role for melatonin in fetal sheep physiology: direct actions of melatonin on fetal cerebral artery, brown adipose tissue and adrenal gland J. Physiol., August 15, 2008; 586(16): 4017 - 4027. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Guillaume, A. M. Daulat, P. Maurice, A. Levoye, M. Migaud, L. Brydon, B. Malpaux, C. Borg-Capra, and R. Jockers The PDZ Protein Mupp1 Promotes Gi Coupling and Signaling of the Mt1 Melatonin Receptor J. Biol. Chem., June 13, 2008; 283(24): 16762 - 16771. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sanchez-Hidalgo, Z. Lu, D.-X. Tan, M. D. Maldonado, R. J. Reiter, and R. I. Gregerman Melatonin inhibits fatty acid-induced triglyceride accumulation in ROS17/2.8 cells: implications for osteoblast differentiation and osteoporosis Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2208 - R2215. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Bernabucci, L. Basirico, N. Lacetera, P. Morera, B. Ronchi, P. A. Accorsi, E. Seren, and A. Nardone Photoperiod Affects Gene Expression of Leptin and Leptin Receptors in Adipose Tissue from Lactating Dairy Cows J Dairy Sci, December 1, 2006; 89(12): 4678 - 4686. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. C. Alonso-Vale, S. Andreotti, S. B. Peres, G. F. Anhe, C. das Neves Borges-Silva, J. C. Neto, and F. B. Lima Melatonin enhances leptin expression by rat adipocytes in the presence of insulin Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E805 - E812. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Slominski, J. Wortsman, and D. J. Tobin The cutaneous serotoninergic/melatoninergic system: securing a place under the sun FASEB J, February 1, 2005; 19(2): 176 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ayoub, A. Levoye, P. Delagrange, and R. Jockers Preferential Formation of MT1/MT2 Melatonin Receptor Heterodimers with Distinct Ligand Interaction Properties Compared with MT2 Homodimers Mol. Pharmacol., August 1, 2004; 66(2): 312 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. CANNON and J. NEDERGAARD Brown Adipose Tissue: Function and Physiological Significance Physiol Rev, January 1, 2004; 84(1): 277 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Masana and M. L. Dubocovich Melatonin Receptor Signaling: Finding the Path Through the Dark Sci. Signal., November 6, 2001; 2001(107): pe39 - pe39. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |